title: Controlled release of benzoyl peroxide from a porous microsphere polymeric system can reduce topical irritancy.
abstract: Skin absorption of benzoyl peroxide from a topical lotion containing freely dispersed drug was compared with that from the same lotion in which the drug was entrapped in a controlled-release styrene-divinylbenzene polymer system. In an in vitro diffusion system, statistically significant (p = 0.01) differences were found in the content of benzoyl peroxide in excised human skin and in percutaneous absorption. In vivo, significantly (p = 0.002) less benzoyl peroxide was absorbed through rhesus monkey skin from the polymeric system. This controlled release of benzoyl peroxide to skin can alter the dose relation that exists between efficacy and skin irritation. Corresponding studies showed reduced skin irritation in cumulative irritancy studies in rabbits and human beings, whereas in vivo human antimicrobial efficacy studies showed that application of the formulations containing entrapped benzoyl peroxide significantly reduced counts of Propionibacterium acnes (p less than 0.001) and aerobic bacteria (p less than 0.001) and the free fatty acid/triglyceride ratio in skin lipids. These findings support the hypothesis that, at least for this drug, controlled topical delivery can enhance safety without sacrificing efficacy.
authors.affiliation: Department of Dermatology, University of California, San Francisco 94143-0989.
authors.forename: R C
authors.initials: RC
authors.lastname: Wester
authors.forename: R
authors.initials: R
authors.lastname: Patel
authors.forename: S
authors.initials: S
authors.lastname: Nacht
authors.forename: J
authors.initials: J
authors.lastname: Leyden
authors.forename: J
authors.initials: J
authors.lastname: Melendres
authors.forename: H
authors.initials: H
authors.lastname: Maibach
mesh_terms: D000279:Administration, Cutaneous; D000328:Adult; D000818:Animals; D001585:Benzoyl Peroxide / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000494:pharmacology; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D007509:Irritants / Q000009:adverse effects; D008253:Macaca mulatta; D008297:Male; D008863:Microspheres; D008875:Middle Aged; D010539:Permeability; D011108:Polymers; D011817:Rabbits; D012867:Skin / Q000187:drug effects / Q000378:metabolism; D012869:Skin Absorption / Q000187:drug effects*
chemical_list: D003692:Delayed-Action Preparations; D007509:Irritants; D011108:Polymers; D001585:Benzoyl Peroxide